| Gilead Signs US$1.53 B Deal with Scholar Rock to Strengthen its Fibrotic Diseases Pipeline |
Abstract
html
pdf
|
|
Sharath Chandra Nakka & Michelle Liu |
|
| Biogen Bolsters Neurology Pipeline with C4 Therapeutics and Skyhawk Deals |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Genentech Pushes for Leadership in Cancer Diagnostics with Adaptive Biotechnologies Deal |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Codiak Biosciences’ Exosome Therapeutics Attracts Jazz Pharmaceuticals |
Abstract
pdf
html
|
|
Michelle Liu |
|
| BMS Latest to Quit Consumer Health with UPSA Divestment |
Abstract
pdf
html
|
|
Jawala Prasad & Michelle Liu |
|
| BMS Acquires Celgene in First Major Deal of 2019 |
Abstract
pdf
|
|
Michelle Liu & Jawala Prasad |
|
| Lilly Bolsters Oncology Pipeline with US$8 B Takeover of Loxo Oncology |
Abstract
pdf
html
|
|
Subham Nandi |
|
| Acrotech Biopharma to Enhance US Presence with Spectrum Pharmaceuticals |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Deal Trends in Immuno-Oncology |
Abstract
pdf
|
|
Natasha Piper, Heather Cartwright & Taskin Ahmed |
|
